Research & Education
CURE Expert Connections
CURE Speaking Out
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
See all >
Acute Myeloid Leukemia
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
See all >
AWARD PROGRAM: Extraordinary Healer
AWARD PROGRAM: Ovarian Cancer Heroes
EDUCATED PATIENT SUMMIT: Lung Cancer
AWARD PROGRAM: Lung Cancer Heroes
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Copper IUD Use Associated with Decreased Cervical Cancer Risk Compared Hormonal Intrauterine System
Women who use copper intrauterine devices (IUD) as a form of birth control may be at lower risk for high-grade cervical cancer compared with those who use a levonorgestrel-releasing intrauterine system.
World Health Organization Outlines Plan to Eliminate Cervical Cancer in Low to Middle Income Countries
The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.
World Cancer Day: 6 Hot Topics Making An Impact In Cancer
For World Cancer Day, here are 6 hot topics making an impact in the cancer space.
CURE's Clinical Trial Corner: Cervical Cancer Edition
Here is a list of clinical trials that are currently happening within the cervical cancer space.
Women Should Be Screened for Cervical Cancer Even as They Age
Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.
Self-Testing for HPV Could Help Reduce Cervical Cancer Rates
A new study suggests distributing self-testing kits by mail helps bring effective testing to underserved populations and makes it easier for women to get tested on their own time.
At-Home Urine Test Could Replace Pap Smear for Cervical Pre-Cancer Screening
Results from a new study suggest there may be a simpler, cheaper, more accessible way to screen for cervical pre-cancer.
Examining Genomics in the Treatment of Cervical Cancer
Researchers from Yale Cancer Center have created a platform to identify genetic mutations that might drive cervical cancer.
Clinical Trial Is Enrolling Patients With Cervical Cancer for Investigational Immunotherapy
Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.
Combination Immunotherapy Shows Promise in Cervical Cancer
Patients with recurrent or metastatic cervical cancer were treated with combination Opdivo and Yervoy in the CheckMate-358 clinical trial.
Not a member?
Sign up now!
Continue without login